Scarica l'app Stockscreener
0.7605
1.74%
-0.0135
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché MBIO Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$0.774
Aprire:
$0.7498
Volume 24 ore:
24,072
Relative Volume:
0.15
Capitalizzazione di mercato:
$5.76M
Reddito:
-
Utile/perdita netta:
$-1.92M
Rapporto P/E:
-1.9415
EPS:
-0.3917
Flusso di cassa netto:
$-5.26M
1 W Prestazione:
+1.54%
1M Prestazione:
+0.60%
6M Prestazione:
-39.64%
1 anno Prestazione:
-33.00%
Intervallo 1D:
$0.7465
$0.774
Intervallo di 1 settimana:
$0.73
$0.794
Portata 52W:
$0.5306
$7.00
Mustang Bio Inc Stock (MBIO) Company Profile
Nome
Mustang Bio Inc
Settore
Industria
Telefono
(781) 652-4500
Indirizzo
95 SAWYER RD, WALTHAM, NY
Compare MBIO vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MBIO
Mustang Bio Inc
|
0.7606 | 5.86M | 0 | -1.92M | -5.26M | -0.3917 |
VRTX
Vertex Pharmaceuticals Inc
|
427.37 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
722.51 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
805.60 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
302.20 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
314.30 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Mustang Bio Inc Stock (MBIO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-05-18 | Iniziato | BTIG Research | Buy |
| 2020-10-02 | Iniziato | B. Riley FBR | Buy |
| 2019-11-20 | Iniziato | Cantor Fitzgerald | Overweight |
| 2019-08-13 | Iniziato | H.C. Wainwright | Buy |
| 2019-06-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2017-12-21 | Iniziato | Oppenheimer | Outperform |
Mostra tutto
Mustang Bio Inc Borsa (MBIO) Ultime notizie
MSN Money - MSN
Mustang Bio (NASDAQ: MBIO) reports Q1 loss, limited cash and Nasdaq bid-price risk - Stock Titan
CAR-T Cell Therapy Market Will Generate Booming Growth Opportunities to 2030 | Novartis, Johnson & Johnson Services, Mustang, Sorrento Therapeutics, Fate Therapeutics etc. - industrytoday.co.uk
Mustang Bio (NASDAQ: MBIO) CEO reports 19-share tax withholding event - Stock Titan
MBIO Mustang Bio posts far wider than expected Q4 2024 loss, shares dip 1.23 percent on soft quarterly performance.NCAV - Newser
MBIO Should I Buy - Intellectia AI
Mustang Bio (MBIO) Stock: Momentum Outlook (-1.95%) 2026-04-20Reversal Setup - Cổng thông tin điện tử tỉnh Lào Cai
Mustang Bio Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Nasdaq warns Mustang Bio (MBIO) on sub-$1 share price and listing risk - Stock Titan
Form S-1General form for registration of securities under the Securities Act of 1933 - ADVFN
Form 10-QQuarterly report [Sections 13 or 15(d)] - ADVFN
Market Pulse: Tech leads gains as consumer sector lags modest advancesStock Idea Sharing Hub - Xã Thanh Hà
Mustang Bio (MBIO) Registration Filing Summary - Quartr
Stock Analysis: Does Mustang Bio Inc have a sustainable dividend2026 Highlights & Entry and Exit Point Strategies - baoquankhu1.vn
If You Invested $1,000 in Mustang Bio (MBIO) - Stock Titan
Is Mustang Bio (MBIO) Stock slowing down | Price at $0.74, Down 0.40%Asset Allocation - Newser
What is the future of Mustang Bio (MBIO) Stock | Price at $0.74, Up 0.27%Social Buzz Stocks - Newser
Will FormFactor (FORM) Stock Outperform Peers | Price at $105.12, Up 0.62%Open Stock Picks - Cổng thông tin điện tử tỉnh Lào Cai
Is Mustang Bio (MBIO) Stock Declining | Price at $0.76, Down 1.68%Senior Analyst Forecasts - Newser
BGMS Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
ERNA PE Ratio & Valuation, Is ERNA Overvalued - Intellectia AI
FBIO SEC FilingsFortress Biotech Inc 10-K, 10-Q, 8-K Forms - Stock Titan
MBIO Stock Price, Quote & Chart | MUSTANG BIO INC (NASDAQ:MBIO) - ChartMill
Levels Update: Can Mustang Bio Inc sustain its profitabilityIndex Update & Capital Protection Trade Alerts - baoquankhu1.vn
Biotech Expansion Accelerating Viral Vector Manufacturing Market Insights 2026–2035 - Weekly Voice
Aug Weekly: Whats the profit margin of Mustang Bio Inc2026 Trends & Expert Approved Trade Ideas - baoquankhu1.vn
Europe Stocks: Research Stocks from Europe Stock Market - GuruFocus
SBFM PE Ratio & Valuation, Is SBFM Overvalued - Intellectia AI
T-cell Therapy Market is Expected to Grow USD 15.3 Billion by 2033 | At CAGR 15.11% - vocal.media
CYCN Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Mustang Bio Inc stock faces prolonged decline amid biotech sector volatility and pipeline uncertaint - AD HOC NEWS
Glioma Pipeline Expands as 180+ Pharma Companies Advance - openPR.com
Mustang Bio, Inc. 2025 Annual Report: Clinical-Stage Biopharmaceutical Pipeline, Risks, and Regulatory Overview - Minichart
Mustang Bio 10-K: Net loss narrows to $(1.9)M; cash $17.3M, runway ≥12 months - TradingView
MBIO: 2025 net loss narrowed to $1.9M, cash rose to $17.3M, and liquidity outlook improved after restructuring - TradingView
Mustang Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Mustang Bio (NASDAQ: MBIO) details GBM pipeline, Orphan status and cash - Stock Titan
Glioma Pipeline Expands As 180+ Pharma Companies Advance Several Novel Therapies, Finds Delveinsight Aivita Biomedical, Denovo Biopharma, Medicenna Therapeutics, Eli Lilly, Candel Therapeutics - Mena FN
Mustang Bio Inc Stock (ISIN: US62815P1003) Faces Analyst Sell Rating Amid Biotech Volatility - AD HOC NEWS
Mustang Bio Shares Surge After FDA Grants Orphan Drug Status - MSN
MBIO Soars on Orphan Drug Nod for Investigational Brain Cancer Therapy - MSN
Is Mustang Bio Inc. stock a safe buy before earnings2026 Institutional & Verified Technical Trade Signals - Naître et grandir
Buy Signal: Is Cheetah Mobile Inc. Depositary Receipt forming a double bottom2025 Geopolitical Influence & Comprehensive Market Scan Reports - baoquankhu1.vn
Is NKSH stock vulnerable to regulatory risksPortfolio Performance Report & Safe Entry Trade Reports - Naître et grandir
Sell Signal: Whats the profit margin of Mustang Bio IncDividend Hike & AI Based Trade Execution Alerts - baoquankhu1.vn
MBIO PE Ratio & Valuation, Is MBIO Overvalued - Intellectia AI
Short Interest in Mustang Bio, Inc. (NASDAQ:MBIO) Rises By 405.2% - Defense World
MBIO Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Critical Contrast: Mustang Bio (NASDAQ:MBIO) & AstraZeneca (NASDAQ:AZN) - Defense World
Market Overview: Is LAND still a buy after recent gainsWeekly Trading Summary & Weekly Breakout Opportunity Watchlist - baoquankhu1.vn
Mustang Bio Inc Azioni (MBIO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.78%
3.01%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):